Previous studies have shown that IP10 chemoattracts CXCR3-positive lymphocytes to tumor areas, and promotes activation of CD4+ Th and CD8+ Tc lymphocytes [22, 26, 44, 45]. Here, CD8A is linked to neoplasm.